Q3 2025 results: Net sales of $533 million (+6% at actual rates); diluted EPS $0.60 Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample ...
Q4 2025 Management View Gunjan Kedia, President, CEO & Director, reported "earnings per share of $1.26, an increase of approximately 18% year-over-year on an adjusted basis" and record net revenues of ...
Mark Van Genderen, President and CEO, opened the call by highlighting the acquisition of Venco Venturo, stating this is "our first acquisition in more than 9 years" and represents a "meaningful first ...
Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. The deal, first announced in ...
Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. NEW YORK CITY, NEW YORK / ACCESS ...